Data / Form D filings / SENEX BIOTECHNOLOGY INC
SENEX BIOTECHNOLOGY INC: Form D filings
SENEX BIOTECHNOLOGY INC, a biotechnology company in Columbia, SC, filed 3 Form D notices with the SEC between 2011 and 2013. The latest, on September 12, 2013, reports $426,079 sold of a $426,079 offering to 1 investor.
Find out what SENEX BIOTECHNOLOGY INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- COKER LIFE SCIENCES BUILDING, ROOM 513, 715 SUMTER ST., Columbia, SC, 29280
- Phone
- (518) 727-5152
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1278295
The full lists. Form D filings in South Carolina: 341 rows, $17.05, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 12, 2013 | New notice | $426,079 | $426,079 | $0 | 1 | Aug 30, 2013 | sec.gov |
| Aug 5, 2013 | New notice | $400,000 | $400,000 | $0 | 2 | Jul 23, 2013 | sec.gov |
| May 11, 2011 | New notice | $200,000 | $200,000 | $0 | 1 | Apr 29, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Lawrence T. Friedhoff | Executive Officer, Director | |
| Richard Davidson | Director | |
| Igor Roninson | Executive Officer, Director |
Every Form D from the week of Sep 9, 2013 · All recent filings in South Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what SENEX BIOTECHNOLOGY INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.